Saturday, August 20, 2011

Awesome and completely true

Really?! Logo Pictures, Images and Photos


 Anyone can benefit from yoga.... provided they can: 


and smile (even if only with your eyes).

Then you should soon

then please visit me and make sure you LIKE ME, click below 



Friday, August 19, 2011

Yoga calms me for today's challenge....

National Insurance not paid when I was sick... and so for my next challenge...

Thank goodness I am a good yogi with reglar practice. Yoga does not make you immune from the stressors of the world but gives me the tools to cope with the challenges pressented!


National insurance paid from th age of 16 until PHI began in  2008, Marrch 2008 - February 2010 pm Permanent Health Insurance. Marrch 2008 - February 2010 ...
Advised had not paid enought National insurance ;-/ awaiting evidence but takes 12-14 wks/
Appealed ?date... must find paperwork that is in a really safe place...
semt for a medical been... and find paperwork in the same really safe place
Job seekers interviewer

1 July I contact my MP Gavin Barwell
5 July his office replied... pending NI statement?? advised of the time dealay but should consider getting pensions estimate
                      ... pension was paid as getting family allowance...
19 August 2011 Emailed from Yorkhshire Building society about PHI and contributions made.:
19 August sent to MS society for them to assess.
9 Septement appointment with Job seekers for esa.....scanned and stored in the really safe place)


19 August 2011 Emailed from Yorkhshire Building society about PHI and contributions made.:

I have looked into your query with regards to your national insurance payments as per your email below.

I can confirm that PHI payments are classed as an income and therefore are subject to National Insurance and tax deductions. Having looked into the payment that you received you were in receipt of £381.25 per month which falls below the Lower Earnings Limit of £442 per month. Therefore you were not paying tax or National Insurance payments during the time you received your benefit.

As requested I have attached the PHI policy.

Should you have any further questions please do not hesitate to contact me.

Kind regards

 * full emailed and PHI document received.

date5 July 2011 10:08
subjectRE: Letter from your constituent Mrs Karen Mascoll.x
Important mainly because of the words in the message.
hide details 5 Jul
Mrs Mascoll
Thank you for contacting Gavin Barwell MP. You mention that you are awaiting a statement of contributions. Once you have received this Gavin would be happy to look further into the matter and this will provide more detail to enable him to ask the right questions.
Could you also confirm when you send this statement to us the dates you were refused benefits, what type of benefit and the reasons you were given, if there were others than just the NI contribution issue.
Sara Bashford
Senior Caseworker for Gavin Barwell MP
133 Wickham Road, Croydon, CR0 8TE
020 8663 8741

-----Original Message-----
From: Mrs Karen Mascoll. []
Sent: 01 July 2011 15:36
To: BARWELL, Gavin
Subject: Letter from your constituent Mrs Karen Mascoll.

                                            Mrs Karen Mascoll.
                                            546 Davidson Road,
                                            CR0 6DG
                                            Phone: 07788 718588
                                            Friday 1 July 2011

Dear Gavin Barwell,
I have discovered that dispite working all since I was 16 and paid my
national isurance contributions. I was diagnosed with Multiple
Sclerosis but managed to continue in my work as a mortgage adviser for
the Yorkshire Building Society Croydon branch and their charitable
represent for London South East. I have spoken the National insurance
people who are sending me a statement of all the national insurance I
have paid. When I was on Permanent Health Insurance no National
insurance was paid for me. NOW when I need help I have been rejected by
the system. IT IS NOT FAIR - I have paid decades of National Insurance
and it counts for NOTHING apparently and I been rejected on ESA claim
because of it... then today I have been for an ESA medical, I went but
what will it achieve.
Yours sincerely,
Karen Mascoll

Thursday, August 18, 2011

Yoga Garden Party

Reflecting on this wonderful day for such a good cause to celebrate as the tt8 Yoga teacher trainers graduation with Simon Lowe's  Simon is now a patron of and we really wanted to Support this worthy cause. A thank you to Simon as well as giving as a little "Yoga gives back"

Photobucket promoted the cause and we organised

I was delighted to receive the email updating of the success of the day (summary below)
Hi everyone,
Firstly thank you so much to everyone for all your hard work yesterday, we all really appreciated how much everyone did!
We have been busy counting the money raised and our current total is a fantastic £3775.30!!
We have already received several messages from people saying how much they enjoyed the day!
Thank you all again, we will be e-mailing those who attended the event to let them know the amount raised.

Vikki, Ruth and Alex
organisers of the Garden Party.


With reflection I suddenly became away of what a wonderful community day a Yoga Garden Party is. I am doing work for the MS society, but that is classes but I am considering how relevant this would be to share with Very pertinent.

Tuesday, August 16, 2011

Sooo busy and soooooooooooo good.

It was May I last posted a blog and time has dashed past. I am going to phone some names. Time to speak to people who have shown an interest. Photobucket
Appointment today with the neurologist and must be focused. Need to discuss :

  • Doctors begin major stem cell trial for MS patients

  • Multiple Sclerosis Pill Fingolimod Not Good Value For NHS Money Says NICE, UK

  • Trials showed the drug, Pill named Fingolimod, halved relapse rates among some patients

  • Ms is genetic... cousin discovery and daughter problems

Bone marrow stem cells Bone marrow stem cells may be able to protect and repair

Related Stories

A major clinical trial will investigate whether stem cells can be safely used to treat multiple sclerosis (MS).
It is hoped eventually to slow, stop or even reverse the damage MS causes to the brain and spinal cord.
The trial, involving up to 150 patients across Europe, is due to start later this year.
Dr Paolo Muraro from Imperial College London said: "There is very strong pre-clinical evidence that stem cells might be an effective treatment."
Researchers will collect stem cells from the bone marrow of patients, grow them in the laboratory and then re-inject them into their blood.
The stem cells will make their way to the brain where it is hoped that they will repair the damage caused by MS.

“Start Quote

These experiments have confirmed that these stem cells hold that potential - but these need to be confirmed in large scale clinical trials”
End Quote Dr Doug Brown MS Society
The research has been part-funded by the UK's MS Society, which is concerned about the availability of unproven stem cell treatments.
In recent years many people living with MS have been attracted to overseas stem cell clinics which claim to cure long-term conditions in exchange for large amounts of money.
But there is no proven stem cell therapy available for MS anywhere in the world.
The MS Society hopes these new trials will eventually lead to a proven treatment - and a reduction in the draw of overseas treatments.
Common condition
MS is the most common neurological condition to affect young people in the UK.
Three million people are thought to be affected worldwide and up to 100,000 in the UK.
The condition is caused by the body's own immune system attacking and damaging a substance called myelin in the brain and nerve cells.

“Start Quote

I am delighted that we have at last progressed stem cell research to this stage, which will bring much-needed hope to so many people affected by this devastating condition”
End Quote Sir Richard Sykes Chair, UK Stem Cell Foundation
The myelin damage disrupts messages from the brain to the body which leads to a number of symptoms such as sight loss, bladder and bowel problems, muscle stiffness and eventually physical disability.
Drugs are available to alleviate the symptoms - but they do not prevent the progression of the condition.
Experiments in test tubes and laboratory animals suggest stem cells extracted from bone marrow may be able to offer a more effective treatment.
Their role in the bone marrow is to protect the cells that make blood. But they also seem to protect myelin from attack by the immune system.
There is also some evidence that these cells might also be able to repair damaged tissue.
Hold potential
Dr Doug Brown, of the MS Society, said: "These experiments have confirmed that these stem cells hold that potential - but these need to be confirmed in large scale clinical trials."
There is some way to go, however, before laboratory promise can be translated into a treatment that can be offered to patients.
The international team will begin so-called phase two clinical trials in six months' time designed to determine whether the treatment is safe and effective.
It will take five years to carry out and assess the results of the trials after which large phase three trials may be required.
But Dr Muraro believes that the stem cell approach has real potential.
He said: "The great hope is the fact that we are exploiting a biological system that has evolved over millions of years and harnessing it for treatment that takes advantage of the stem cells' flexibility."
Sir Richard Sykes, chair of the UK Stem Cell Foundation, said Dr Muraro's research was the first of its kind to take place in the UK.
"Given the high incidence of MS in the UK in comparison to other countries, I am delighted that we have at last progressed stem cell research to this stage, which will bring much-needed hope to so many people affected by this devastating condition."
Correction 29 July 2011: This story has been amended after the MS Society corrected a statement it had made suggesting stem cells from the brains of aborted foetuses had been used in research it was funding. The society said that adult neural cells were in fact being used.

Help include BBC interview..

The first pill that could help relieve the early stages of multiple sclerosis is being made available.
It offers an alternative to those failing on the current treatments of injections and hospital infusions.
Trials showed the drug, named Fingolimod, halved relapse rates among some patients.
It is estimated that 100,000 people in the UK have MS.
The NHS advisory body, the National Institute for Health and Clinical Excellence (NICE), is now reviewing the drug to assess the cost effectiveness of the new treatment. Its recommendations will decide if the drug will be made freely available to NHS patients in England. It costs approximately £20,000 a year to treat a patient.
Sam Sheppard, who has had MS for five years, joins BBC Breakfast together with Dr Doug Brown, head of biomedical research at the MS Society.


to what triggers MS

In MS, the immune system attacks myelin in nerve fibres In MS, the immune system attacks myelin in nerve fibres

Multiple Sclerosis

  • MS is the most common disabling neurological disease among young adults
  • It affects around 100,000 people in the UK
  • MS is most often diagnosed in people between the ages of 20 and 40
  • Research suggests that a combination of genetic and environmental factors may play a role in its development
  • There is around a 2%chance of a child developing MS when a parent is affected
  • MS is almost unknown in places like Malaysia or Ecuador, but relatively common in the UK, North America, Canada, Scandinavia, southern Australia and New Zealand
  • Source: MS Society
It looked at DNA from almost 10,000 MS patients, and more than 15,000 healthy controls.
Twenty three known genetic variations, common in the general population, that give a tiny increase in the risk of getting MS were confirmed, and 29 new ones identified.
Another five are strongly suspected as being involved, bringing the total number of genetic variations associated with MS to 57.
Professor Alistair Compston of the University of Cambridge told the BBC: "This is suddenly a big new number of genes to try to understand.
"80% of the genes that are implicated by the 57 'hits' are immunological. This shouts out that this is an immunological disease at the beginning. This is a very important confirmation."
Around 2.5 million people around the world have MS, 100,000 of them in the UK.
MS is not directly inherited and there is no single gene that causes it. However, research suggests a combination of genes common in the general population make some people more susceptible to developing the neurological disorder.
Other environmental factors are involved, possibly something in the environment, such as a virus or bacteria, or Vitamin D from exposure to sunlight.
Simon Gillespie, Chief Executive of the MS Society said: "By identifying which genes may trigger the development of MS, we can identify potential 'risk factors' and look at new ways of treating, or even preventing, the condition in the future."
Some of the genes found to be important in MS are also implicated in other autoimmune disorders, such as Crohn's disease and Type 1 diabetes, a separate research paper, published in PLoS Genetics, has reported.